MINT-IMATINIB

Product Overview

About MINT-IMATINIB

MINT-IMATINIB is a prescription medication containing the active ingredient Imatinib Mesylate, a tyrosine kinase inhibitor used in the treatment of certain types of cancer, including Chronic Myeloid Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST).

Key Benefits & Uses

• Treatment of Chronic Myeloid Leukemia (CML) in adult patients with a Philadelphia chromosome-positive (Ph+) status.
• Treatment of Gastrointestinal Stromal Tumors (GIST) in adults.
• Management of Blast Crisis, Accelerated Phase, or Chronic Phase of CML in adult patients with a Ph+ status.

Active Ingredient & Action

Imatinib Mesylate, the active ingredient in MINT-IMATINIB, works by inhibiting the activity of tyrosine kinases, enzymes responsible for the activation of proteins involved in cell growth and division. By blocking these enzymes, Imatinib Mesylate helps to slow or stop the growth of cancer cells.

Important Notes

MINT-IMATINIB should only be used under the guidance of a qualified healthcare professional. Patients should be aware of the potential side effects, including nausea, vomiting, diarrhea, and fatigue. Regular monitoring of blood counts and liver function is recommended. It is essential to follow the prescribed dosage and treatment schedule to ensure the effectiveness and safety of the medication.